Rapid organic growth in Europe, Middle East, and Latin America sets the stage for further global expansion
Company names John Liljequist as the Director of Sales for Asia Pacific
NATICK, Mass., July 29 (Bernama-BUSINESS WIRE) -- Allurion Technologies, a pioneering leader in the development of innovative, scalable, and trusted weight loss experiences, today announced entry into Asia with the launch of the Elipse Program in Hong Kong, Malaysia, and Singapore. Building upon its success in Europe, Middle East, and Latin America, the company’s entry into Asia could impact the lives of over 1 billion people who are overweight or obese in a region that historically has had limited access to non-invasive weight loss treatments.¹
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200728005010/en/
"With the launch of our weight loss program in Asia, our company enters its next phase of rapid expansion,” said Allurion co-founder and Chief Executive Officer, Shantanu Gaur, M.D. “Obesity has been on the rise in Asia for decades, but truly frictionless treatment options have been absent. We intend to change that.”
Allurion has already treated over 25,000 individuals in over 30 countries around the world with its 360-degree Allurion weight loss program. According to a study released by the Asian Development Bank Institute, over 40% of adults in Asia are overweight or obese, an increase of close to 20% in just the past 20 years.
"The arrival of the Elipse Balloon in Gleneagles Hospital Penang was a historical moment for all of us involved,” said Dr. Kirubakaran Malapan of Gleneagles Hospital Penang. “I am very confident that this will be an appealing treatment option in our fight against obesity.”
ALLURION EXPANDS INTO ASIA WITH LAUNCH OF THE ELIPSE® GASTRIC BALLOON WEIGHT LOSS PROGRAM
No comments:
Post a Comment